系统活检在PI-RADS 5病变靶向活检中不贡献疾病升级
本研究回顾性分析148例既往前列腺活检后接受MRI靶向活检(MRI-TB)联合系统12针活检(SB)的患者,比较联合与单独MRI-TB对高PI-RADS病变的诊断价值。结果显示PI-RADS 5病变的MRI-TB无升级率仅3.4%,提示可安全单独行MRI-TB;而PI-RADS 3和4病变需联合SB。
要点
- PI-RADS 5病变单独MRI-TB无升级率仅3.4%,可安全避免系统活检。
- PI-RADS 3和4病变联合系统活检有助于准确疾病管理。
- MRI-TB总体无升级率为26.2%,各PI-RADS亚组差异显著。
核心结论
- PI-RADS 5病变的MRI靶向活检无升级率极低,可单独行MRI-TB而不联合SB。
- PI-RADS 3和4病变应联合SB以提高准确管理。
研究设计与样本
- 回顾性分析148例既往有前列腺活检史、因可疑MRI病变行MRI-TB+SB的患者。
- 共分析255个病变,其中247个PI-RADS≥3。
主要发现
- 141个病变(55.3%)较前次活检升级,其中MRI-TB升级104个(40.8%),SB升级87个(34.1%)。
- MRI-TB总体无升级率为26.2%。
- PI-RADS 3、4、5的MRI-TB无升级率分别为39.3%、21.2%、3.4%。
关键数值与推荐
- 升级定义为任何先前活检的Gleason评分增加。
- 无升级MRI-TB定义为与SB相比未导致疾病升级的MRI-TB。
临床怎么用
- PI-RADS 5病变可单独行MRI靶向活检,避免系统活检。
- PI-RADS 3和4病变应联合系统活检以准确评估疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the utility of the systematic 12-core prostate biopsy (SB) combined with magnetic resonance imaging (MRI)-targeted lesion biopsy (MRI-TB) vs MRI-TB alone in the diagnosis of high PI-RADS lesions. MATERIALS AND METHODS: Patients undergoing MRI-TB + SB for suspicious MRI lesions were retrospectively reviewed. These patients had a previous prostate biopsy and were evaluated with MRI to assess the need for a repeat biopsy. Pathologic findings of MRI-TB combined with a SB were compared to those of the patients' previous SB. An upgrade was defined as an increase in the Gleason Score of any prior biopsy. A no-upgrade (NU) MRI-TB was defined as a MRI-TB that did not lead to disease upgrading when compared to SB. RESULTS: A total of 148 patients were analyzed in this study. Of the 255 total lesions (247 lesions with PI-RADS ≥3), 141 were upgraded from the previous biopsy (55.3%). Of these, 104 were upgraded by the MRI-TB (40.8%), and 87 lesions were upgraded by the SB (34.1%). The MRI-TB had a NU rate of 26.2% for all lesions. On subanalysis, the NU rates of PI-RADS 3, 4, and 5 MRI-TBs were 39.3%, 21.2%, and 3.4%, respectively. CONCLUSION: The NU rate for the MRI-TB in a PIRADS-5 lesion is meager. Men with a PI-RADS 5 lesion may be safely managed with the MRI-TB alone without combining with SB. Men with PI-RADS 3 and 4 lesions should benefit from SB in addition to MRI-TB for accurate management of their disease.
引用
- Arabi A, Deebajah M, Yaguchi G, et al. Systematic Biopsy Does Not Contribute to Disease Upgrading in Patients Undergoing Targeted Biopsy for PI-RADS 5 Lesions Identified on Magnetic Resonance Imaging in the Course of Active Surveillance for Prostate Cancer. Urology. 2019. PMID: 31479660. doi:10.1016/j.urology.2019.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。